CN101474249B - 益母草及其制剂的质量检测方法 - Google Patents
益母草及其制剂的质量检测方法 Download PDFInfo
- Publication number
- CN101474249B CN101474249B CN2009101138253A CN200910113825A CN101474249B CN 101474249 B CN101474249 B CN 101474249B CN 2009101138253 A CN2009101138253 A CN 2009101138253A CN 200910113825 A CN200910113825 A CN 200910113825A CN 101474249 B CN101474249 B CN 101474249B
- Authority
- CN
- China
- Prior art keywords
- mobile phase
- reference substance
- water
- preparation
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 49
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 title claims abstract description 19
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 title claims abstract description 19
- 238000003908 quality control method Methods 0.000 title description 4
- 240000007890 Leonurus cardiaca Species 0.000 title description 2
- 238000000034 method Methods 0.000 claims abstract description 88
- 238000012360 testing method Methods 0.000 claims abstract description 45
- 239000007788 liquid Substances 0.000 claims abstract description 34
- 238000000105 evaporative light scattering detection Methods 0.000 claims abstract description 24
- 241000207925 Leonurus Species 0.000 claims abstract description 17
- 239000013558 reference substance Substances 0.000 claims description 52
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 45
- DUNMULOWUUIQIL-RGMNGODLSA-N (2s)-1,1-dimethylpyrrolidin-1-ium-2-carboxylic acid;chloride Chemical compound Cl.C[N+]1(C)CCC[C@H]1C([O-])=O DUNMULOWUUIQIL-RGMNGODLSA-N 0.000 claims description 33
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 22
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 15
- 238000011003 system suitability test Methods 0.000 claims description 15
- 239000003729 cation exchange resin Substances 0.000 claims description 14
- 239000000945 filler Substances 0.000 claims description 14
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 claims description 14
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 13
- 239000002253 acid Substances 0.000 claims description 13
- 238000003556 assay Methods 0.000 claims description 13
- 238000009472 formulation Methods 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- CBHOOMGKXCMKIR-UHFFFAOYSA-N azane;methanol Chemical compound N.OC CBHOOMGKXCMKIR-UHFFFAOYSA-N 0.000 claims description 11
- 239000003480 eluent Substances 0.000 claims description 11
- 239000012528 membrane Substances 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 10
- 239000000741 silica gel Substances 0.000 claims description 10
- 229910002027 silica gel Inorganic materials 0.000 claims description 10
- FPLYNRPOIZEADP-UHFFFAOYSA-N octylsilane Chemical group CCCCCCCC[SiH3] FPLYNRPOIZEADP-UHFFFAOYSA-N 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000005374 membrane filtration Methods 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 4
- 230000002349 favourable effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 77
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 18
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 16
- 238000001514 detection method Methods 0.000 description 11
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 10
- 239000000523 sample Substances 0.000 description 10
- 239000000377 silicon dioxide Substances 0.000 description 10
- 239000008187 granular material Substances 0.000 description 8
- 229960001866 silicon dioxide Drugs 0.000 description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- CMUNUTVVOOHQPW-LURJTMIESA-N L-proline betaine Chemical compound C[N+]1(C)CCC[C@H]1C([O-])=O CMUNUTVVOOHQPW-LURJTMIESA-N 0.000 description 5
- 239000012567 medical material Substances 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- 239000012488 sample solution Substances 0.000 description 5
- CMUNUTVVOOHQPW-ZCFIWIBFSA-N stachydrine Natural products C[N+]1(C)CCC[C@@H]1C([O-])=O CMUNUTVVOOHQPW-ZCFIWIBFSA-N 0.000 description 5
- 239000002775 capsule Substances 0.000 description 4
- 239000012846 chemical reference substance Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 229940023488 pill Drugs 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- WNGSUWLDMZFYNZ-UHFFFAOYSA-N Leonurine Chemical compound COC1=CC(C(=O)OCCCCN=C(N)N)=CC(OC)=C1O WNGSUWLDMZFYNZ-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 235000011158 Prunus mume Nutrition 0.000 description 2
- 244000018795 Prunus mume Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000000149 argon plasma sintering Methods 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- VELYAQRXBJLJAK-MJSCJBMMSA-N Leonuridine Chemical compound C12C(C)(O)CC(O)C2C=COC1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VELYAQRXBJLJAK-MJSCJBMMSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229940046011 buccal tablet Drugs 0.000 description 1
- 239000006189 buccal tablet Substances 0.000 description 1
- 229940023913 cation exchange resins Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- -1 patch Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000013094 purity test Methods 0.000 description 1
- 238000012207 quantitative assay Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009101138253A CN101474249B (zh) | 2009-01-19 | 2009-01-19 | 益母草及其制剂的质量检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009101138253A CN101474249B (zh) | 2009-01-19 | 2009-01-19 | 益母草及其制剂的质量检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101474249A CN101474249A (zh) | 2009-07-08 |
CN101474249B true CN101474249B (zh) | 2012-02-22 |
Family
ID=40835087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009101138253A Active CN101474249B (zh) | 2009-01-19 | 2009-01-19 | 益母草及其制剂的质量检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101474249B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103245753A (zh) * | 2013-04-25 | 2013-08-14 | 昆明中药厂有限公司 | 一种益母颗粒的质量检测方法 |
CN105911188A (zh) * | 2016-04-25 | 2016-08-31 | 广西壮族自治区梧州食品药品检验所 | 快速萃取-液质串联检测妇康宁片中盐酸水苏碱含量的方法 |
CN107290441A (zh) * | 2017-03-29 | 2017-10-24 | 广西壮族自治区梧州食品药品检验所 | 一种ase‑hplc法测定益母草中盐酸水苏碱含量的方法 |
CN107389827A (zh) * | 2017-08-18 | 2017-11-24 | 山东省食品药品检验研究院 | 益母草或其复方制剂中盐酸水苏碱含量的测定方法 |
CN110057945A (zh) * | 2019-05-29 | 2019-07-26 | 南京市中西医结合医院 | 益母草的质量检测方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1877322A (zh) * | 2005-06-10 | 2006-12-13 | 上海华拓医药科技发展有限公司 | 一种益母草中水苏碱含量的高效液相色谱检测方法 |
-
2009
- 2009-01-19 CN CN2009101138253A patent/CN101474249B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1877322A (zh) * | 2005-06-10 | 2006-12-13 | 上海华拓医药科技发展有限公司 | 一种益母草中水苏碱含量的高效液相色谱检测方法 |
Non-Patent Citations (3)
Title |
---|
余琪等.《益母草中盐酸水苏碱的HPLC测定.《中国医药工业杂志》.2006,第37卷(第1期),34-35. * |
冯旭等.HPLC-ELSD测定益母颗粒中盐酸水苏碱的含量.《中成药》.2008,第30卷(第5期),附件2. * |
赵雪梅等.HPLC法测定杜仲降压片中水苏碱的含量.《齐鲁药事》.2006,(第05期), * |
Also Published As
Publication number | Publication date |
---|---|
CN101474249A (zh) | 2009-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101474249B (zh) | 益母草及其制剂的质量检测方法 | |
CN102000140A (zh) | 一种苦参药材及其制剂中苦参碱和氧化苦参碱同时定量新方法 | |
CN102119961A (zh) | 一种复方丹参滴丸的检测方法 | |
CN111239282B (zh) | 一种测定血液中苯巴比妥的方法、试剂盒及应用 | |
CN103926332B (zh) | 一种同时测定半夏提取物中尿苷、鸟苷和腺苷含量的超高效液相色谱方法 | |
CN102552496A (zh) | 复方胃痛胶囊的质量检测方法 | |
CN108709949B (zh) | 一种发酵虫草菌粉Cs-4中药饮片的检测方法 | |
CN103063789A (zh) | 同时检测大叶蒟中12个酰胺类生物碱的液相分析方法 | |
Bhushan et al. | TLC supplemented by UV spectrophotometry compared with HPLC for separation and determination of some antidiabetic drugs in pharmaceutical preparations | |
CN102507831B (zh) | 全蚕粉中1-脱氧野尻霉素含量的测定方法 | |
CN101721530B (zh) | 金鸡制剂的检测方法 | |
CN1877322B (zh) | 一种益母草中水苏碱含量的高效液相色谱检测方法 | |
CN111912916A (zh) | 一种佛手制剂中指标成分含量的测定方法 | |
CN101816753B (zh) | 一种治疗感冒的复方制剂的质量检测方法 | |
CN108414667B (zh) | 一种参桂益心颗粒质量标准的检测方法 | |
CN104034838A (zh) | 罗汉果止咳糖浆的质量检测方法 | |
CN100480698C (zh) | 一种降压药物的检测方法 | |
CN103454374B (zh) | 骨康药物的检测方法 | |
CN101926889A (zh) | 芍杞颗粒剂的检测方法 | |
WO2009155756A1 (zh) | 巴戟天中药材或其提取物中巴戟天寡糖的含量测定方法 | |
CN112666278A (zh) | 华佗再造丸中士的宁的限量检测方法 | |
CN107807182B (zh) | 灵芝糖浆中灵芝酸a成分的含量测定方法 | |
CN106053685B (zh) | 一种测定乐舒洗液中黄柏碱含量的spe‑hplc法 | |
CN102854282B (zh) | 一种治疗喉症的中药复方制剂的检测方法 | |
CN110161169A (zh) | 一种水环境中多种药物活性物质的快速检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: LINGFENG PHARMACEUTICAL CO., LTD., GUANGXI Free format text: FORMER OWNER: GUANGDONG HUIKE PHARMACEUTICAL RESEARCH COMPANY LIMITED Effective date: 20130930 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Huang Yuan Inventor after: Rong Yanli Inventor after: Chen Xiaojun Inventor after: Mo Shaohong Inventor after: Liao Zhanwei Inventor before: Huang Yuan Inventor before: Liang Yuezhao Inventor before: Chen Xiaojun Inventor before: Mo Shaohong |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: HUANG YUAN LIANG YUEZHAO CHEN XIAOJUN MO SHAOHONG TO: HUANG YUAN RONG YANLI CHEN XIAOJUN MO SHAOHONG LIAO ZHANWEI Free format text: CORRECT: ADDRESS; FROM: 530003 NANNING, GUANGXI ZHUANG AUTONOMOUS REGION TO: 542899 HEZHOU, GUANGXI ZHUANG AUTONOMOUS REGION |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130930 Address after: 542899 No. 68 West Anshan Road, the Guangxi Zhuang Autonomous Region, Hezhou Patentee after: Guangxi LingFeng Pharmaceutical Co.,Ltd. Address before: 530003 development center, 56 Garden Avenue, Nanning, the Guangxi Zhuang Autonomous Region Patentee before: Guangxi Huike Medicine Research Co.,Ltd. |
|
CP03 | Change of name, title or address |
Address after: No. 68, Anshan West Road, Babu District, Hezhou City, Guangxi Zhuang Autonomous Region Patentee after: Jinji Pharmaceutical Co.,Ltd. Address before: 542899 No. 68 West Anshan Road, the Guangxi Zhuang Autonomous Region, Hezhou Patentee before: Guangxi LingFeng Pharmaceutical Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200108 Address after: 535416, Lingshan Qinzhou land Industrial Park, the Guangxi Zhuang Autonomous Region Patentee after: GUANGXI GEHONGTANG PHARMACEUTICAL Co.,Ltd. Address before: No. 68, Anshan West Road, Babu District, Hezhou City, Guangxi Zhuang Autonomous Region Patentee before: Jinji Pharmaceutical Co.,Ltd. |